The variables with p < 0.2 were sex, age, BSA, dose intensity of gemcitabine, presence of liver metastasis, prior chemotherapy for pancreatic cancer, prior Tegafur Gimeracil Oteracil Potassium, RBC, PLT, Neutr, Lymph, ALP, ALT, UN, and CRP on day 1. Here, CRP is linked to familial pancreatic carcinoma.